Similar articles

• Human papillomavirus: Current prevalence and future protection.

  Bauer HM, Ault K. Bauer HM, et al. Sex Transm Dis. 2006 Aug;33(8):509-11. doi: 10.1097/01.olq.0000225323.51240.bc. Sex Transm Dis. 2006. PMID: 16865048 No abstract available.
• Human papillomavirus infection among sexually active young women in the United States: Implications for developing a vaccination strategy.

  Manhart LE, Holmes KK, Koutsky LA, Wood TR, Kenney DL, Feng Q, Kiviat NB. Manhart LE, et al. Sex Transm Dis. 2006 Aug;33(8):502-8. doi: 10.1097/01.olq.0000204545.89516.0a. Sex Transm Dis. 2006. PMID: 16572039
• Prevention strategies of cervical cancer in the HPV vaccine era.

  Bosch X, Harper D. Bosch X, et al. Gynecol Oncol. 2006 Oct;103(1):21-4. doi: 10.1016/j.ygyno.2006.07.019. Epub 2006 Aug 17. Gynecol Oncol. 2006. PMID: 16919714 Review. No abstract available.
• HPV vaccination: more questions than answers.

  Noller KL. Noller KL. Obstet Gynecol. 2006 Jan;107(1):4-5. doi: 10.1097/01.AOG.0000194478.64329.94. Obstet Gynecol. 2006. PMID: 16394032 No abstract available.
• Human papillomavirus vaccines in development: if they're successful in clinical trials, how will they be implemented?

  Shaw AR. Shaw AR. Gynecol Oncol. 2005 Dec;99(3 Suppl 1):S246-8. doi: 10.1016/j.ygyno.2005.07.097. Epub 2005 Oct 5. Gynecol Oncol. 2005. PMID: 16213009 Review.